1. "2020"
Formats
  1. Journal Article (2337)
  2. Meeting Abstract (1901)
  3. Review (494)
  4. Editorial (342)
  5. Correspondence (121)
  6. Guidelines (114)
  7. Book Section (99)
  8. Research Letter (95)
  9. Miscellaneous (61)
  10. Conference Paper (33)
  11. Book Whole (2)
Groups
  1. Department of Medicine (2560)
  2. Solid Tumor Oncology Division (1535)
  3. GSK Faculty (1257)
  4. Sloan Kettering Institute Postdocs (1240)
  5. Hematologic Malignancies, Division of (936)
  6. Survivorship Research (930)

More Groups

People
  1. Jorge Reis-Filho (93)
  2. Miguel-Angel Perales (93)
  3. Sergio Giralt (91)
  4. Alexander Drilon (81)
  5. Britta Weigelt (76)
  6. Nadeem Abu-Rustum (71)

More People

Years
  1. 2020 (5599)
Publications
  1. Journal of Clinical Oncology (500)
  2. Blood (212)
  3. Cancer Research (185)
  4. Annals of Oncology (152)
  5. International Journal of Radiation Oncology, Biology, Physics (129)
  6. Laboratory Investigation (116)

More Publications

Publishers
  1. Elsevier Inc. (714)
  2. American Society of Clinical Oncology (548)
  3. Nature Publishing Group (385)
  4. American Association for Cancer Research (357)
  5. Oxford University Press (356)
  6. Springer (342)

More Publishers

Results (5599)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CONTESSA 2: A multinational, multicenter, phase 2 study of tesetaxel plus a reduced dose of capecitabine in patients with HER2-, HR+ metastatic breast cancer (MBC) who have not previously received a taxane
    Meeting Abstract

    Schwartzberg, L.; Asselah, J.; Bondarenko, I.; Chae, Y.; DaCosta, N.; Feng, Y. H.; Izarzugaza, Y.; Lemieux, J.; Liu, M. C.; Marx, G.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Capivasertib and paclitaxel in first-line treatment of patients with metastatic triple-negative breast cancer: A phase III trial (CAPItello-290)
    Meeting Abstract

    Schmid, P.; Cortes, J.; Robson, M.; Iwata, H.; Hegg, R.; Verma, S.; Nechaeva, M.; Xu, B.; Haddad, V.; Imedio, E. R.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Regional management of the axilla prior to systemic therapy
    Meeting Abstract

    Pilewskie, M.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Treatment patterns for metastatic hormone receptor-positive breast cancer: Comparing expert and community practice
    Meeting Abstract

    Quill, T.; Hurvitz, S.; Miller, K. D.; O'Regan, R.; Traina, T. A.; Andrie, R.; Obholz, K. L.; Jahanzeb, M.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • OlympiAD extended follow-up for overall survival and safety: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer
    Meeting Abstract

    Robson, M.; Im, S. A.; Senkus, E.; Xu, B.; Domchek, S.; Masuda, N.; Delaloge, S.; Li, W.; Tung, N.; Armstrong, A.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • The genomic landscape of endocrine-resistant metastatic breast cancer
    Meeting Abstract

    Razavi, P.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays in triple negative breast cancer
    Meeting Abstract

    Reisenbichler, E. S.; Han, G.; Pelekanou, V.; Yaghoobi, V.; Ahmed, F. S.; Bellizzi, A.; Bossuyt, V.; Brock, J.; Cole, K.; Fadare, O.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • CONTESSA: A multinational, multicenter, randomized, phase 3 registration study of tesetaxel plus a reduced dose of capecitabine in patients with HER2-, hormone receptor + (HR+) metastatic breast cancer (MBC) who have previously received a taxane
    Meeting Abstract

    O'Shaughnessy, J.; Piccart, M.; Schwartzberg, L.; Cortes, J.; Harbeck, N.; Im, S. A.; Rugo, H.; Untch, M.; Yardley, D.; Bondarenko, I.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Patient reported outcomes from the adjuvant trastuzumab emtansine (T-DM1) vs. paclitaxel + trastuzumab (TH) (ATEMPT) trial (TBCRC 033)
    Meeting Abstract

    Partridge, A.; Zheng, Y.; Rosenberg, S.; Gelber, R.; Gelber, S.; Barry, W.; Dang, C.; Yardley, D.; Isakoff, S.; Valero, V.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • The genomic landscape of metastatic special histologic types of breast cancer
    Meeting Abstract

    Pareja, F.; Lee, S. S. K.; Beca, F.; Ferrando, L.; Selenica, P.; Brown, D. N.; Wen, H. Y.; Zhang, H.; Brogi, E.; Razavi, P.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save